Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Group 3 received 0.25 mg of AOD9604 per 0.6 mL injection, and Group 4 received a combination of AOD9604 at 0.25 mg and HA at 6 mg
This blend combines two well-studied regenerative peptides: BPC-157 (Body Protection Compound-157), a pentadecapeptide derived from human gastric juice with cytoprotective and wound-healing properties [1] [2] , and TB-500 (Thymosin Beta-4 fragment), a 43-amino-acid peptide involved in tissue repair, cell migration, and angiogenesis [3] [4]
One person may care about gut support
Quick answer: In the Phase 2 clinical trial (Jastreboff et al., 2023, New England Journal of Medicine ), retatrutide was given by once-weekly subcutaneous injection across a 112mg range
Select an appointment time and complete a short medical questionnaire
US$ 25.36
US$ 23.72
US$ 24.85
